Los Angeles Times, January 25, 2011
Last December, a specialty pharmacy in Florida enjoyed its best month ever, posting a hefty $168.7 million in revenues. But it wasn't filling prescriptions that made Ven-A-Care of the Florida Keys Inc. such a success. Tiny Ven-A-Care has developed a lucrative niche market: blowing the whistle on drug companies that overcharge Medicare and Medicaid and collecting tens of millions of dollars in reward money. Unlike most whistle-blowers who help the government with one case after they encounter wrongdoing, Ven-A-Care has filed suits alleging fraudulent conduct against dozens of drug companies supplying pharmacies and healthcare providers.